Home ›
Trademark Categories ›
Pharmaceuticals ›
2021 ›
DE ›
DELIX THERAPEUTICS
Trademark search for:
DELIX THERAPEUTICS
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2021-05-12 — Application filed
2021-05-15 — Application filed
2021-08-12 — Application filed
2022-01-19 — Assigned to examiner
2022-01-19 — Final disposition recorded
2022-01-19 — Final disposition recorded
2022-01-19 — Final disposition recorded
2022-02-18 — Office action issued
2022-02-18 — Correspondence received in law office
2022-02-19 — Teas/email correspondence entered
2022-02-23 — Approved for pub - principal register
2022-03-09 — Notification of notice of publication e-mailed
2022-03-29 — Published for opposition
2022-03-29 — Official gazette publication confirmation e-mailed
2022-04-25 — Teas post publication amendment received
2022-04-27 — Extension of time to oppose received
2022-05-16 — Assigned to petition staff
2022-05-20 — Post publication amendment - entered
2022-08-07 — Extension of time to oppose process - terminated
2022-09-20 — Noa e-mailed - sou required from applicant
2023-03-15 — Teas revoke/app/change addr of atty/dom rep received
2023-03-15 — Attorney/dom.rep.revoked and/or appointed
2023-03-15 — Teas withdrawal of attorney received-firm retains
2023-03-15 — Teas change of correspondence received
2023-03-17 — Sou teas extension received
2023-03-17 — Sou extension 1 filed
2023-03-17 — Sou extension 1 granted
2023-03-21 — Notice of approval of extension request e-mailed
2023-08-28 — Sou teas extension received
2023-08-28 — Sou extension 2 filed
2023-08-28 — Sou extension 2 granted
2023-08-30 — Notice of approval of extension request e-mailed
2024-02-20 — Sou teas extension received
2024-02-20 — Sou extension 3 filed
2024-02-20 — Sou extension 3 granted
2024-02-21 — Notice of approval of extension request e-mailed
2024-08-06 — Teas revoke/app/change addr of atty/dom rep received
2024-08-06 — Attorney/dom.rep.revoked and/or appointed
2024-08-06 — Teas change of correspondence received
2024-08-06 — Teas withdrawal of attorney received-firm retains
2024-08-06 — Sou teas extension received
2024-08-06 — Sou extension 4 filed
2024-08-06 — Sou extension 4 granted
2024-08-06 — Notice of approval of extension request e-mailed
2025-02-09 — Sou extension 5 filed
2025-02-10 — Sou teas extension received
2025-05-21 — Case assigned to intent to use paralegal
2025-05-21 — Sou extension 5 granted
2025-05-22 — Notice of approval of extension request e-mailed
2025-10-27 — Application abandoned
2025-10-27 — Application abandoned
2025-10-27 — Final status recorded
Owner Information
Delix Therapeutics, Inc.
Delix Therapeutics, Inc.
Correspondent
Chidera N. Dawodu WILSON SONSINI GOODRICH & ROSATI
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
